Adults with type 2 diabetes using a GLP-1 receptor agonist have a similar risk for developing thyroid cancer as those using a ...

Key Takeaways Medicare will negotiate prices for Ozempic and 14 other drugs in 2025, with prices taking effect in ...

Former Trump administration health official Joe Grogan applauds Biden proposal that Medicare and Medicaid cover GLP-1 ...

A nationwide study confirms GLP-1 RAs pose no short-term psychiatric risk, showing a negative association with suicidal ...

In a large population of people with diabetes, the use of GLP-1 receptor agonists was not linked to an increased risk for ...

Elon Musk/X Mounjaro, like Ozempic, is a GLP-1 inhibitor – a class of drugs developed to help people with diabetes regulate their blood glucose and insulin levels. However, Americans have ...

Both Ozempic and Mounjaro are GLP-1 inhibitors meant to help people with diabetes, but they are often used for weight loss. He said the GLP-1 “seems to have fewer side effects and be more ...

With the holidays past and the new year arrived, we look ahead — to losing weight. For some that resolve theoretically ...

Diet food brands have been hit in recent years, but now GLP-1 drugs like Ozempic are hitting the market, will this spell the ...

Kennedy Jr. over the widespread use and long-term benefits of GLP-1 inhibitors in battling obesity. Posting to his social media platform X (formerly Twitter), Musk shared an image of himself ...

In previous First Word columns, I discussed the effects of SGLT2 inhibitors on the kidney to prevent progression of chronic ...

Icovamenib & BMF-650 (oral small molecule GLP-1) are the cornerstones of the metabolic franchiseBiomea preparing icovamenib for late-stage ...